The objectives of this study were to describe anxiety and depression levels 
among acoustic neuroma patients; examine differences in anxiety and depression 
across the acoustic neuroma management options of microsurgery, radiation and 
observation; and to investigate management, medical and demographic factors that 
might predict anxiety and depression in this patient group. A cross-sectional 
questionnaire was completed by 205 adults diagnosed with, or treated for, a 
unilateral acoustic neuroma within five years of questionnaire distribution. 
Median age of participants was 57.0 years, and 120 (58.5%) were female. Anxiety 
and depression were measured using the Hospital Anxiety and Depression Scale 
(HADS). Clinically significant anxiety was reported by 29.8% of participants and 
10.2% were depressed. Mean anxiety and depression scores did not differ from 
general population norms. No significant differences in anxiety and depression 
were found across management options. Time since management, number of symptoms 
and comorbid medical conditions predicted anxiety, while depression was 
predicted by number of symptoms. This appears to be the first study among 
acoustic neuroma patients in which anxiety and depression were compared across 
management options. Treating physicians should be aware that as the number of 
acoustic neuroma symptoms increases, so may the likelihood of clinically 
significant anxiety and depression.